Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewVL 285 is an E3 ubiquitin ligase VHL inhibitor (IC50= 340 nM). VL 285 treatment competitively reduces or reverses target protein degradation by AU-15330 and HaloPROTAC3 Degraders.
M. Wt | 532.66 |
Formula | C29H32N4O4S |
Storage | Store at -20°C |
Purity | ≥97% (HPLC) |
CAS Number | 1448188-57-5 |
PubChem ID | 71667162 |
InChI Key | HEDFFPYRFJKXQP-VJTSUQJLSA-N |
Smiles | CC1=C(C2=CC=C(CNC([C@H]3N(C([C@@H](N4CC(C=CC=C5)=C5C4=O)C(C)C)=O)C[C@H](O)C3)=O)C=C2)SC=N1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 26.63 | 50 | |
ethanol | 10.65 | 20 |
The following data is based on the product molecular weight 532.66. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.5 mM | 3.75 mL | 18.77 mL | 37.55 mL |
2.5 mM | 0.75 mL | 3.75 mL | 7.51 mL |
5 mM | 0.38 mL | 1.88 mL | 3.75 mL |
25 mM | 0.08 mL | 0.38 mL | 0.75 mL |
References are publications that support the biological activity of the product.
Buckley et al (2015) HaloPROTACS: use of small molecule PROTACs to induce degradation of HaloTag fusion proteins. ACS Chem.Biol. 10 1831 PMID: 26070106
Xiao et al (2022) Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer. Nature 601 434 PMID: 34937944
If you know of a relevant reference for VL 285, please let us know.
Keywords: VL 285, VL 285 supplier, VL285, von, hippel, lindau, ligand, E3, ubiquitin, ligase, inhibitor, inhibitors, inhibits, VHL, degradation, Ubiquitin, Ligases, 7903, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for VL 285. Do you know of a great paper that uses VL 285 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review VL 285 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
This brochure highlights the tools and services available from Bio-Techne to support your Targeted Protein Degradation and Induced Proximity research, including:
There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.
Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia